Neural Mechanisms of Spatial Representations Beyond the Self

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorBoston University Charles River Campus

About this trial

Spatial navigation is a fundamental human behavior, and deficits in navigational functions are among the hallmark symptoms of severe neurological disorders such as Alzheimer's disease. Understanding how the human brain processes and encodes spatial information is thus of critical importance for the development of therapies for affected patients. Previous studies have shown that the brain forms neural representations of spatial information, via spatially-tuned activity of single neurons (e.g., place cells, grid cells, or head direction cells), and by the coordinated oscillatory activity of cell populations. The vast majority of these studies have focused on the encoding of self-related spatial information, such as one's own location, orientation, and movements. However, everyday tasks in social settings require the encoding of spatial information not only for oneself, but also for other people in the environment. At present, it is largely unknown how the human brain accomplishes this important function, and how aspects of human cognition may affect these spatial encoding mechanisms. This project therefore aims to elucidate the neural mechanisms that underlie the encoding of spatial information and awareness of others. Specifically, the proposed research plan will determine how human deep brain oscillations and single-neuron activity allow us to keep track of other individuals as they move through our environment. Next, the project will determine whether these spatial encoding mechanisms are specific to the encoding of another person, or whether they can be used more flexibly to support the encoding of moving inanimate objects and even more abstract cognitive functions such as imagined navigation. Finally, the project will determine how spatial information is encoded in more complex real-world scenarios, when multiple information sources (e.g., multiple people) are present. To address these questions, intracranial medial temporal lobe activity will be recorded from two rare participant groups: (1) Participants with permanently implanted depth electrodes for the treatment of focal epilepsy through responsive neurostimulation (RNS), who provide a unique opportunity to record deep brain oscillations during free movement and naturalistic behavior; and (2) hospitalized epilepsy patients with temporarily implanted intracranial electrodes in the epilepsy monitoring unit (EMU), from whom joint oscillatory and single-neuron activity can be recorded.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Between 18 and 70 years of age

Adequate visual and auditory acuity to allow neuropsychological testing

Have undergone depth electrode placement for the purpose of epilepsy evaluation/treatment OR have NeuroPace RNS System implanted for epilepsy treatment

Disqualifiers

All DSM-V Axis I and II disorders other than nicotine-dependence

History of brain damage

Trial design

Design model

Single group

Treatments tested in this trial

  • Self-navigation task

    Behavioral

    Participants will perform a self-navigation task with two experimental conditions: Either they will be asked to walk towards a visible wall-mounted sign, or they will be asked to find and learn a hidden target location within the experimental room.

  • Observation task

    Behavioral

    Participants will sit on a chair in a corner of the room (RNS participants) or watch a video that was recorded from the corner of the room (EMU participants). They will be asked to keep track of another person's location who is walking around the room, and to press a button whenever the other person crosses a previously-learned target location.

Treatment groups

60 Participants
are divided into 1 treatment group
Group A: Electrophysiological recordings in participants with intracranially implanted electrodesOther 2 interventions

Trial outcomes

Primary outcomes

1

Oscillatory power

It will be measured how the oscillatory power (measurement unit: microvolts-squared) of electrophysiological brain activity, as measured via intracranially implanted electrodes and an electroencephalography recording system, is modulated by task-related behavioral variables (such as the individual's spatial location, head direction, movement speed, or their distance/direction to environmental boundaries).

Time frame
Continuous measurement during task performance on day 1 and all subsequent measurement days (up to 14 days per participant)
2

Oscillatory amplitude

It will be measured how the oscillatory amplitude (measurement unit: microvolts) of electrophysiological brain activity, as measured via intracranially implanted electrodes and an electroencephalography recording system, is modulated by task-related behavioral variables (such as the individual's spatial location, head direction, movement speed, or their distance/direction to environmental boundaries).

Time frame
Continuous measurement during task performance on day 1 and all subsequent measurement days (up to 14 days per participant)
3

Oscillatory frequency

It will be measured how the frequency of an oscillation (measurement unit: Hertz), as measured via intracranially implanted electrodes and an electroencephalography recording system, is modulated by task-related behavioral variables (such as the individual's spatial location, head direction, movement speed, or their distance/direction to environmental boundaries).

Time frame
Continuous measurement during task performance on day 1 and all subsequent measurement days (up to 14 days per participant)
4

Firing rate of single neurons

It will be measured how the firing rate of single neurons (measurement unit: Hertz), as measured via intracranially implanted micro-electrodes and an electrophysiology recording system, is modulated by task-related behavioral variables (such as the individual's spatial location, head direction, movement speed, or their distance/direction to environmental boundaries).

Time frame
Continuous measurement during task performance on day 1 and all subsequent measurement days (up to 14 days per participant)

Secondary outcomes

Other outcomes

1

Eye movement speed

It will be measured how eye movements (specifically, the speed of eye movements, quantified as changes in pupil position; measurement unit: degrees per second), as measured with a mobile eye tracking system, are modulated by task-related behavioral variables (such as the individual's spatial location, head direction, movement speed, or their distance/direction to environmental boundaries). These eye tracking data will also be used for control analyses, to test whether the primary outcome measures (electrophysiological activity change) are influenced by eye movements.

Time frame
Continuous measurement during task performance on day 1 and all subsequent measurement days (up to 14 days per participant)

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Boston University Charles River Campus

Lead sponsor

National Institute of Neurological Disorders and Stroke (NINDS)

Collaborator

National Institutes of Health (NIH)

Collaborator

Boston Medical Center

Collaborator